Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Kim R. Tsuchimoto currently holds 11,486 shares of Monopar Therapeutics (MNPR), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Kim R. Tsuchimoto has been a net seller of MNPR stock. They have purchased $2.6K and sold $443.6K worth of shares.
Kim R. Tsuchimoto's most recent insider trade was on Jul 14, 2025, when they sold 8,904 shares at $40.00 per share.
Kim R. Tsuchimoto serves as Executive at Monopar Therapeutics (MNPR). They have executed 54 insider transactions totaling $446.2K over their tenure at the company.
Kim R. Tsuchimoto holds the position of Executive at Monopar Therapeutics, where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 19 years and currently hold a stake valued at $0.
Kim R. Tsuchimoto has shown a selling trading pattern, with $2.6K in total purchases and $443.6K in total sales across all transactions. Their most recent activity indicates a tendency to reduce their position.
The largest transaction by Kim R. Tsuchimoto was on Jul 14, 2025, when they sold $356.2K worth of MNPR shares. This transaction involved 8,904 shares at $40.00 per share.
Kim R. Tsuchimoto currently owns 11,486 shares of Monopar Therapeutics (MNPR), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Kim R. Tsuchimoto's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Kim R. Tsuchimoto has 54 Form 4 filings on record as an insider at Monopar Therapeutics.
Set alerts for Kim R. Tsuchimoto and 40,000+ other insiders.